Back to Results
First PageMeta Content
Fibrates / Organochlorides / Cardiology / Lipoproteins / Fenofibrate / Statin / Bezafibrate / Low-density lipoprotein / Gemfibrozil / Chemistry / Organic chemistry / Medicine


Document Date: 2006-04-05 16:23:37

Open Document

File Size: 98,43 KB

Share Result on Facebook

City

Edmonton / /

Company

Comp Inc. / Heart Protection Study Collaborative Group / Ericsson / The Canadian Working Group / /

Country

Canada / /

Currency

pence / /

Facility

University of Alberta / Grey Nuns Hospital / /

IndustryTerm

prevention of ischemic heart disease / Treatment for obesity / prevention of coronary heart disease / /

MedicalCondition

severe coronary artery disease / insulin resistance / hypertension / hyperinsulinemia / vein-graft atherosclerosis / abdominal obesity / cholelithiasis / myopathy / mixed hyperlipidemia / coronary stenosis / ischemic heart disease / familial combined dyslipidemia / dyslipidemia / subsequent rhabdomyolysis / cardiovascular disease / diabetes / increases hypoglycemia / familial hypertriglyceridemia / Other Dyslipidemias / mild mixed dyslipidemia / signif icant hypertriglyceridemia / metabolic syndrome / hepatic dysfunction / renal insufficiency / myocardial infarction / obesity / Coronary-Artery Disease / hypercholesterolemia / low HDL cholesterol / coronary artery disease / coronary heart disease / renal failure / acute pancreatitis / MS / dyslipidemia pattern / Hypercholesterolemia / gallstones / /

MedicalTreatment

statin therapy / drug therapy / /

Organization

World Health Organization / Grey Nuns Hospital / Committee of Principal Investigators / University of Alberta / /

Person

K. Lee / Hugo / /

Position

author / candidate for combination therapy / clinical professor / Rubins HB / professor of medicine / /

Product

Heart Protection Study.12 Drug / triad / simvastatin / Lopid / Gemfibrozil / fenofibrate / Lipidil / clofibrate / /

ProvinceOrState

Alberta / /

Technology

alpha / /

SocialTag